ArticlePakistan journal of medical sciences2025
The efficacy of Fire dragon cupping combined with Shaofu Zhuyu decoction in treating primary dysmenorrhea with cold coagulation and blood stasis.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effects of fire dragon cupping therapy for patients with post-stroke shoulder-hand syndrome: a systematic review and meta-analysis.Frontiers in neurology · 2026Pooled it
- Pharmacological Effects of Wenjing Decoction in a Rat Model of Cold Coagulation and Blood Stasis Primary Dysmenorrhea: An Integrated Analysis of Serum Pharmacochemistry, Network Pharmacology and Metabolomics.Pharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the efficacy of Fire Dragon Cupping (FDC) combined with Shaofu Zhuyu Decoction (SFZYD) in the treatment of primary dysmenorrhea (PD) with cold coagulation and blood stasis (CCBS). Methodology: A retrospective case-control analysis was conducted at the Department of Gynecology, Hebei Provincial Hospital of Traditional Chinese Medicine (TCM). All participants were selected from a registry of PD CCBS patients who received treatment between October 2022 to May 2024. Patients were retrospectively assigned according to the treatment received to either the SFZYD group or the FDC + SFZYD group. The primary outcome of interest was the TCM syndrome score. The secondary outcomes included changes in visual analogue scale (VAS), uterine artery hemodynamic status, endothelin-1 (ET-1) and nitric oxide (NO) levels. Results: This study included a total of 112 patients, 54 patients in the SFZYD group and 58 patients in the FDC & SFZYD group. After treatment, the TCM syndrome score and VAS score in the PDC & SFZYD group were significantly lower than those in the SFZYD group ( Conclusions: The combination of FDC and SFZYD can more effectively reduce the pain level of PD patients with CCBS, alleviate clinical symptoms, regulate the hemodynamic status of uterine arteries and the levels of ET-1 and NO than SFZYD alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.